2 Stocks Under $20: Immunitybio and Lemonade

Both stocks are ripe for a short squeeze

Deputy Editor
Mar 20, 2024 at 2:55 PM
facebook X logo linkedin

Depending on who you ask, a recession is either right around the corner, or the stock market is ready to rattle off a seismic bull run. As always, the answer is probably something in the middle of those two extremes. But due to the uncertainty surrounding the Federal Reserve’s rate cuts, investors are stuck in a holding pattern until more data defines the country's fiscal path.

Since bargains become popular when times are uncertain, we’d like to introduce a new weekly segment: Cheap Seats. Every week, we will profile two stocks under $20 with a market capitalization of at least $2 billion.

These are not outright "buy" recommendations, but interesting names – with cheap overhead – that are worth adding to your watch list. This week, we're taking a look at biotech stock Immunitybio Inc (NASDAQ:IBRX) and Lemonade Inc (MYSE:LMND)

IBRX is surging today, following the company's better-than-expected earnings report -- up 10.5% to trade at $6.07 at last glance, though still sitting at a reasonably priced $6. The stock is a far cry from its record high of $45.42 on Feb. 22, 2021, and has been in and out of penny stock territory for the past two years.

In the short term, there is plenty of short interest that could lend itself to a short squeeze, as the 51.55 million shares sold short represent 39.5% of IBRX's available float. There is plenty of space for bull notes as well, as there are only two analysts in coverage.

The shares of Lemonade are also on the rise today, up 4.8% to trade at $16.49 at last glance. Notably, the insurance company's business model strongly centers around the use of artificial intelligence (AI), a boon for many stocks this year. Since last March, the equity is up 21.9%. Lemonade stock also has plenty of pessimism that could unwind, as short interest represents 31.2% of the stock's available float. 

When weighing in on LMND, options look like a good way to go. The stock is seeing well-priced premium at the moment, per its Schaeffer's Volatility Index (SVI) of 56% ranks in the low 3rd percentile of its annual range. 



Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI